Dose-response and dose-survival advantage for high versus low-dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer a southwest oncology group study (Q72722085)
scientific article published on 01 March 1984
Language:
(P31) (Q13442814)
(P304) 1029-1035
(P407) (Q1860)
(P433) 5
(P478) 53
(P577) Thursday, March 1, 1984
(P921) (Q282629)
(Q412415)
(Q162555)
(P953) https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19840301)53:5%3C1029::AID-CNCR2820530503%3E3.0.CO;2-Z
https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19840301)53:5%3C1029::AID-CNCR2820530503%3E3.0.CO;2-Z
(P1433) (Q326041)
(P1476) "Dose-response and dose-survival advantage for high versus low-dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer. A Southwest Oncology Group study" (language: en)
"Dose-response and dose-survival advantage for high versus low-dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer a southwest oncology group study" (language: en)
(P2093) M. K. Samson
S. E. Rivkin
S. E. Jones
J. J. Costanzi
A. F. LoBuglio
R. L. Stephens
E. A. Gehan
G. D. Cummings
(P2860) (Q79059277)
(Q71416380)
(Q27710278)
(Q27710278)
(Q39452307)
(Q27710285)
(Q40859025)
(Q72628912)
(Q400279)
(Q76688739)
(Q27710285)
(Q44949634)
(Q25938997)
(Q56428666)
(Q72154949)
(Q70170309)
other details
description scientific article published on 01 March 1984

External Links